Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Lurbinectedin has emerged as a potential treatment option for relapsed small cell lung cancer (SCLC).
Lurbinectedin monotherapy is currently FDA approved for the treatment of adult patients with metastatic Small-Cell-Lung-Cancer (SCLC)
see also:
Chemotherapy (CT) & Small-Cell-Lung-Cancer (SCLC)
…